Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lotus Pharmaceuticals Inc (LTUS)
OTHER OTC:LTUS
Lotus Pharmaceuticals (LTUS) Stock Price & Analysis
4 Followers
LTUS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume27.00K
Average Volume (3M)N/A
Market Cap
$104.31K
Enterprise Value$5.36M
Total Cash (Recent Filing)$158.91K
Total Debt (Recent Filing)$5.41M
Price to Earnings (P/E)―
Beta0.53
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,694,515,543
10 Day Avg. Volume500
30 Day Avg. VolumeN/A
Standard Deviation0.48
R-Squared0.00116
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.08
Enterprise Value/Gross Profit0.13
Enterprise Value/Ebitda1.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.14% Other Institutional Investors
99.86% Public Companies and
Individual Investors
LTUS FAQ
What was Lotus Pharmaceuticals Inc’s price range in the past 12 months?
Currently, no data Available
What is Lotus Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Lotus Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lotus Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Lotus Pharmaceuticals Inc overvalued?
According to Wall Street analysts Lotus Pharmaceuticals Inc’s price is currently Overvalued.
Does Lotus Pharmaceuticals Inc pay dividends?
Lotus Pharmaceuticals Inc does not currently pay dividends.
What is Lotus Pharmaceuticals Inc’s EPS estimate?
Lotus Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Pharmaceuticals Inc have?
Lotus Pharmaceuticals Inc has 27,816,000 shares outstanding.
What happened to Lotus Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lotus Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in LTUS
---
Lotus Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
290.49%
Trailing 12-Months
Company Description
Lotus Pharmaceuticals Inc
Lotus Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products in the People's Republic of China. Its products are prescription medicines, including valsartan, used to reduce hypertension and high blood pressure; brimonidine tartrate, used to constrict adrenaline receptors; levofloxacin lactate, an intravenous anti-bacterial drug; and nicergoline, an anti-dementia drug. The company also distributes products on behalf of third party pharmaceutical manufacturers directly through its distribution network. Lotus Pharmaceuticals was founded by Zhongyi Liu in 1996 and is headquartered in Beijing, China.
---
---